We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » UK’s Antitrust Authority: Actavis Inflated Prices of Hydrocortisone Generics by 12,000%
UK’s Antitrust Authority: Actavis Inflated Prices of Hydrocortisone Generics by 12,000%
UK’s antitrust agency has accused Actavis of breaching competition law by raising the price of generic hydrocortisone tablets for Addison’s disease by more than 12,000 percent since 2008.